clonazepam has been researched along with citalopram in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.90) | 18.2507 |
| 2000's | 13 (44.83) | 29.6817 |
| 2010's | 12 (41.38) | 24.3611 |
| 2020's | 2 (6.90) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Jolivette, LJ; Ward, KW | 1 |
| Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Stein, MB | 1 |
| Baldwin, DS; Birtwistle, J | 1 |
| Sachdev, P | 1 |
| Freeman, SA | 1 |
| Dunner, DL | 1 |
| Harrison-Woolrych, M; McLean, RM | 1 |
| Bhatia, MS; Gupta, R | 1 |
| Varma, A; Wickham, R | 1 |
| Agarwal, S; Chattaraj, TK; Gowda, KV; Pal, TK; Selvan, PS | 1 |
| Hoge, EA; Lebeau, RT; Moshier, SJ; Otto, MW; Pollack, MH; Simon, NM; Thompson, EH; Worthington, JJ; Zalta, AK | 1 |
| Greenberg, D; Jaworowski, S; Lerner, V; Mergui, J | 1 |
| Gadapayale, KK; Kakde, MG; Kakde, RB; Satone, DD | 1 |
| Gadit, A | 1 |
| Basu, B; De, S; Dutta, N; Gangopadhyay, T; Mandal, B; Mondal, S | 1 |
| Kurkjian, C; Kurkjian, N; Pant, S; Tucker, P | 1 |
| Lubszky, S; Reinhart, WH; Schulzki, T; Thöny, S | 1 |
| Bonan, CD; Lara, DR; Piato, AL; Schaefer, IC; Siebel, AM; Vianna, MR | 1 |
| Bhave, S; Faye, A; Gawande, S; Kirpekar, V; Tadke, R | 1 |
| Kanwar, P; Kumar, R; Sharma, RC | 1 |
| Uvais, NA | 1 |
| Bottega, A; Coelho, SS; Foletto, VS; Hörner, R; Lorenzoni, VV; Machado, CS; Mainardi, A; Rampelotto, RF; Rosa, TFD; Serafin, MB | 1 |
3 review(s) available for clonazepam and citalopram
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Medication treatments for panic disorder and social phobia.
Topics: Antidepressive Agents, Tricyclic; Benzamides; Benzodiazepines; Citalopram; Clinical Trials as Topic; Clomipramine; Clonazepam; Dose-Response Relationship, Drug; Female; Humans; Male; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Piperidines; Recurrence; Selective Serotonin Reuptake Inhibitors; Social Behavior Disorders | 1998 |
The side effect burden associated with drug treatment of panic disorder.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Citalopram; Clonazepam; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors | 1998 |
2 trial(s) available for clonazepam and citalopram
| Article | Year |
|---|---|
Bioequivalence of two commercial preparations of escitalopram oxalate/clonazepam using a liquid chromatography-electrospray mass spectrometry method.
Topics: Adult; Area Under Curve; Calibration; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Citalopram; Clonazepam; Confidence Intervals; Cross-Over Studies; Double-Blind Method; Drug Combinations; GABA Modulators; Humans; Male; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Spectrometry, Mass, Electrospray Ionization; Therapeutic Equivalency; Young Adult | 2008 |
Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
Topics: Adult; Anticonvulsants; Citalopram; Clonazepam; Cognitive Behavioral Therapy; Combined Modality Therapy; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Resistance; Female; Humans; Longitudinal Studies; Male; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome | 2009 |
24 other study(ies) available for clonazepam and citalopram
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Extrapolation of human pharmacokinetic parameters from rat, dog, and monkey data: Molecular properties associated with extrapolative success or failure.
Topics: Algorithms; Animals; Dogs; Haplorhini; Humans; Pharmaceutical Preparations; Pharmacokinetics; Rats; Species Specificity; Tissue Distribution | 2005 |
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Citalopram-Clonazepam combination for primary depersonalization disorder: a case report.
Topics: Adult; Citalopram; Clonazepam; Depersonalization; Female; GABA Modulators; Humans; Selective Serotonin Reuptake Inhibitors | 2002 |
Panic attacks with spontaneous ejaculation successfully treated with citalopram and clonazepam.
Topics: Adult; Citalopram; Clonazepam; Ejaculation; Humans; Male; Panic Disorder; Sexual Dysfunction, Physiological | 2004 |
Interactive case conference. First episode: depression and panic disorder.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Citalopram; Clonazepam; Depression; Drug Therapy, Combination; Female; Humans; Lithium Carbonate; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2005 |
Alopecia associated with quetiapine.
Topics: Adult; Affective Disorders, Psychotic; Alopecia; Antipsychotic Agents; Azabicyclo Compounds; Bipolar Disorder; Citalopram; Clonazepam; Dibenzothiazepines; Female; Humans; Hypnotics and Sedatives; Piperazines; Quetiapine Fumarate | 2007 |
Pica responding to SSRI: an OCD spectrum disorder?
Topics: Adult; Anticonvulsants; Citalopram; Clonazepam; Drug Therapy, Combination; Female; Humans; Obsessive-Compulsive Disorder; Pica; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2009 |
Ziprasidone-associated mania in a case of obssessive-compulsive disorder.
Topics: Anticonvulsants; Bipolar Disorder; Citalopram; Clonazepam; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Thiazoles | 2007 |
Shared obsessive-compulsive disorder: broadening the concept of shared psychotic disorder.
Topics: Citalopram; Clonazepam; Female; GABA Modulators; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Shared Paranoid Disorder; Spouses; Treatment Outcome | 2010 |
Stability-indicating RP-HPLC method for the simultaneous determination of escitalopram oxalate and clonazepam.
Topics: Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Citalopram; Clonazepam; Drug Stability; Reproducibility of Results; Sensitivity and Specificity; Tablets | 2013 |
Persistent genital arousal disorder: a clinical challenge.
Topics: Antidepressive Agents, Second-Generation; Azabicyclo Compounds; Citalopram; Clonazepam; Female; GABA Modulators; Humans; Hypnotics and Sedatives; Middle Aged; Piperazines; Psychotherapy; Sexual Dysfunctions, Psychological; Treatment Failure | 2013 |
A case of akathisia induced by escitalopram: case report & review of literature.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Second-Generation; Breast Neoplasms; Citalopram; Clonazepam; Depressive Disorder; Female; Humans; Middle Aged; Muscle Relaxants, Central; Propranolol; Psychomotor Agitation; Selective Serotonin Reuptake Inhibitors | 2014 |
Psycho-oncology: a brief history and case study.
Topics: Antidepressive Agents, Second-Generation; Carcinoma, Squamous Cell; Citalopram; Clonazepam; Depressive Disorder; Esophageal Neoplasms; Esophagectomy; Female; GABA Modulators; Humans; Middle Aged; Neoadjuvant Therapy | 2013 |
Interaction of injectable neurotropic drugs with the red cell membrane.
Topics: Central Nervous System Agents; Chlorpromazine; Citalopram; Clomipramine; Clonazepam; Diazepam; Erythrocytes; Humans; Injections; Levetiracetam; Microscopy, Electron, Scanning; Neurotransmitter Agents; Phenobarbital; Phenytoin; Piracetam; Valproic Acid | 2014 |
The side-by-side exploratory test: a simple automated protocol for the evaluation of adult zebrafish behavior simultaneously with social interaction.
Topics: Animals; Bromazepam; Buspirone; Citalopram; Clonazepam; Dose-Response Relationship, Drug; Exploratory Behavior; Fear; Female; Fluoxetine; Male; Pattern Recognition, Automated; Psychological Tests; Psychotropic Drugs; Social Behavior; Software; Stress, Psychological; Vision, Ocular; Zebrafish | 2015 |
Obsession of pregnancy: Does it exist?
Topics: Attitude to Health; Citalopram; Clomipramine; Clonazepam; Cognitive Behavioral Therapy; Depressive Disorder; Diagnosis, Differential; Female; Fluoxetine; GABA Modulators; Humans; Middle Aged; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 2017 |
Cannabis induced koro in a Nepali migrant.
Topics: Adult; Cannabis; Citalopram; Clonazepam; GABA Modulators; Humans; Koro; Male; Nepal; Olanzapine; Selective Serotonin Reuptake Inhibitors; Transients and Migrants | 2018 |
Psychological Impact of the COVID-19 Pandemic Among the Elderly: A Case Series From India.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Anxiety Agents; Antidepressive Agents; Betacoronavirus; Citalopram; Clonazepam; Coronavirus Infections; COVID-19; Depressive Disorder; Female; Humans; India; Lorazepam; Male; Mirtazapine; Pandemics; Panic Disorder; Pneumonia, Viral; SARS-CoV-2 | 2020 |
Repurposing of escitalopram oxalate and clonazepam in combination with ciprofloxacin and sulfamethoxazole-trimethoprim for treatment of multidrug-resistant microorganisms and evaluation of the cleavage capacity of plasmid DNA.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Citalopram; Clonazepam; DNA; Drug Repositioning; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Plasmids; Sulfamethoxazole; Trimethoprim | 2021 |